The present invention relates to the process for the preparation of Apixaban polymorphic form N-1 of formula (I) having a particle size diameter D90 greater than100 µm using roller compaction technology.
An improved process for the preparation 3-chloro-2-hydroxypropanoic acid of formula (I) by using continuous stirring tank reactors (CSTRs) technology.
The above intermediate of formula (I) is to provide industrially viable and inherently safer process with high yield and purity.
The compound of formula (...
The present invention relates to process for the preparation of Brivaracetam having the structural formula (I).
The present invention also relates to novel intermediates which are useful in the preparation of Brivaracetam.
The present invention relates to process for the preparation of Levetiracetam having the structural formula (I).
The present invention also relates to process for the preparation of (S)-2-amino-butyric acid methyl ester compound of Formula (V).
Charges
0
08 August 2013
Export-import Bank Of India
30 Crore
22 November 2012
State Bank Of India
150 Crore
08 August 2013
Export-import Bank Of India
36 Crore
27 June 2014
Bank Of India
20 Crore
08 August 2013
Export-import Bank Of India
10 Crore
08 August 2013
Sbi Global Factors Limited
15 Crore
08 August 2013
Export-import Bank Of India
0
08 August 2013
Export-import Bank Of India
0
27 June 2014
Bank Of India
0
08 August 2013
Sbi Global Factors Limited
0
22 November 2012
State Bank Of India
0
08 August 2013
Export-import Bank Of India
0
08 August 2013
Export-import Bank Of India
0
08 August 2013
Export-import Bank Of India
0
27 June 2014
Bank Of India
0
08 August 2013
Sbi Global Factors Limited
0
22 November 2012
State Bank Of India
0
08 August 2013
Export-import Bank Of India
0
08 August 2013
Export-import Bank Of India
0
08 August 2013
Export-import Bank Of India
0
27 June 2014
Bank Of India
0
08 August 2013
Sbi Global Factors Limited
0
22 November 2012
State Bank Of India
0
08 August 2013
Export-import Bank Of India
0
Documents
Form INC-28-20042018-signed
Optional Attachment-(1)-13042018
Copy of court order or NCLT or CLB or order by any other competent authority.-13042018
List of share holders, debenture holders;-26022018
Approval letter for extension of AGM;-26022018
Copy of MGT-8-26022018
Form MGT-7-26022018_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-22012018
Optional Attachment-(1)-22012018
Approval letter of extension of financial year of AGM-22012018
Form AOC-4(XBRL)-22012018_signed
Letter of the charge holder stating that the amount has been satisfied-22082017
Form CHG-4-22082017_signed
CERTIFICATE OF SATISFACTION OF CHARGE-20170822
Optional Attachment-(2)-04072017
Optional Attachment-(1)-04072017
Notice of resignation;-04072017
Form DIR-12-04072017_signed
Evidence of cessation;-04072017
Proof of dispatch-30062017
Notice of resignation filed with the company-30062017
Form DIR-11-30062017_signed
Acknowledgement received from company-30062017
Form MGT-14-20062017_signed
Optional Attachment-(2)-20062017
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-20062017
Optional Attachment-(1)-20062017
Form MGT-14-17062017_signed
Optional Attachment-(1)-16062017
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-16062017